Literature DB >> 3968433

2-Chloroadenosine: a selective lethal effect to mouse macrophages and its mechanism.

T Saito, J Yamaguchi.   

Abstract

In our studies on the effects of purine compounds on immune responses in vitro, we found that 2-chloroadenosine (2-Cl Ado) exhibited a potent lethal effect on a viability of mouse adherent cells derived from the peritoneal cavity. The lethal effect was specific for adherent peritoneal cells (PC) (macrophages) and was prevented by exogenous addition of adenosine (Ado) or coformycin, a potent inhibitor of adenosine deaminase. A rapid decrease of intracellular ATP content (26% of control) in adherent PC was observed soon after 1 hr exposure to 2-Cl Ado (0.1 mM), and this decrease of ATP was comparable with that of monoiodoacetate (MIA, 0.1 mM)- or NaN3 (5 mM)-treated adherent PC. The ATP decrease by 2-Cl Ado was restored to 88 or 90% of control value by 1 hr addition of Ado or coformycin, respectively. Polymorphonuclear cells and lymphocytes to which 2-Cl Ado did not exhibit the lethal effect did not cause a significant ATP decrease of the cells. Therefore, the data suggested that the reason for the lethal effect on adherent PC treated with 2-Cl Ado could be attributed to a rapid decrease of ATP content at an early time. We assume that 2-Cl Ado competes with intracellular Ado in macrophages and then causes the adenosine starvation resulting in the ATP decrease.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3968433

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  7 in total

1.  A novel bioaction of PAF: induction of microbicidal activity in guinea pig bone marrow cells.

Authors:  H Hayashi; I Kudo; T Kato; R Nozawa; S Nojima; K Inoue
Journal:  Lipids       Date:  1988-12       Impact factor: 1.880

Review 2.  Extracellular and intracellular action of clodronate in osteolytic bone diseases? A hypothesis.

Authors:  N van Rooijen
Journal:  Calcif Tissue Int       Date:  1993-06       Impact factor: 4.333

3.  Induction of an endogenous tumor necrosis factor in mice by murine recombinant interferon-gamma combined with a lipid A subunit analog (GLA-60) of low toxicity.

Authors:  I Saiki; H Maeda; T Sakurai; J Murata; J Iida; M Kiso; A Hasegawa; I Azuma
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Antimetastatic effects of synthetic polypeptides containing repeated structures of the cell adhesive Arg-Gly-Asp (RGD) and Tyr-Ile-Gly-Ser-Arg (YIGSR) sequences.

Authors:  I Saiki; J Murata; J Iida; T Sakurai; N Nishi; K Matsuno; I Azuma
Journal:  Br J Cancer       Date:  1989-11       Impact factor: 7.640

5.  Oral administration of a Kampo (Japanese herbal) medicine Juzen-taiho-to inhibits liver metastasis of colon 26-L5 carcinoma cells.

Authors:  Y Ohnishi; H Fujii; Y Hayakawa; R Sakukawa; T Yamaura; T Sakamoto; K Tsukada; M Fujimaki; S Nunome; Y Komatsu; I Saiki
Journal:  Jpn J Cancer Res       Date:  1998-02

6.  CXCL16 suppresses liver metastasis of colorectal cancer by promoting TNF-α-induced apoptosis by tumor-associated macrophages.

Authors:  Ji-Ye Kee; Aya Ito; Shozo Hojo; Isaya Hashimoto; Yoshiko Igarashi; Koichi Tsuneyama; Kazuhiro Tsukada; Tatsuro Irimura; Naotoshi Shibahara; Ichiro Takasaki; Akiko Inujima; Takashi Nakayama; Osamu Yoshie; Hiroaki Sakurai; Ikuo Saiki; Keiichi Koizumi
Journal:  BMC Cancer       Date:  2014-12-15       Impact factor: 4.430

7.  Recombinant fusion polypeptide with cell- and heparin-binding domains of fibronectin inhibits liver metastasis of L5178Y-ML25 lymphoma cells.

Authors:  I Saiki; Y Matsumoto; J Murata; T Makabe; J Yoneda; H Okuyama; F Kimizuka; Y Ishizaki; I Kato; I Azuma
Journal:  Jpn J Cancer Res       Date:  1991-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.